L1CAM malfunction in the nervous system and human carcinomas

被引:0
作者
Michael K. E. Schäfer
Peter Altevogt
机构
[1] University of Freiburg,Center for Neurosciences, Institute of Anatomy and Cell Biology
[2] German Cancer Research Center,D015
来源
Cellular and Molecular Life Sciences | 2010年 / 67卷
关键词
Cell adhesion molecule; Neurological disorders; L1 syndrome; Cancer; Cell migration;
D O I
暂无
中图分类号
学科分类号
摘要
Research over the last 25 years on the cell adhesion molecule L1 has revealed its pivotal role in nervous system function. Mutations of the human L1CAM gene have been shown to cause neurodevelopmental disorders such as X-linked hydrocephalus, spastic paraplegia and mental retardation. Impaired L1 function has been also implicated in the aetiology of fetal alcohol spectrum disorders, defective enteric nervous system development and malformations of the renal system. Importantly, aberrant expression of L1 has emerged as a critical factor in the development of human carcinomas, where it enhances cell proliferation, motility and chemoresistance. This discovery promoted collaborative work between tumour biologists and neurobiologists, which has led to a substantial expansion of the basic knowledge about L1 function and regulation. Here we provide an overview of the pathological conditions caused by L1 malfunction. We further discuss how the available data on gene regulation, molecular interactions and posttranslational processing of L1 may contribute to a better understanding of associated neurological and cancerous diseases.
引用
收藏
页码:2425 / 2437
页数:12
相关论文
共 50 条
  • [41] Endoplasmic Reticulum Malfunction in the Nervous System
    Jung, Joanna
    Michalak, Marek
    Agellon, Luis B.
    FRONTIERS IN NEUROSCIENCE, 2017, 11
  • [42] Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT
    Doberstein, Kai
    Harter, Patrick N.
    Haberkorn, Uwe
    Bretz, Niko P.
    Arnold, Bernd
    Carretero, Rafael
    Moldenhauer, Gerhard
    Mittelbronn, Michel
    Altevogt, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E326 - E339
  • [43] L1CAM as a Negative Prognostic Factor in Endometrioid Endometrial Adenocarcinoma FIGO Stage IA-IB
    Klat, Jaroslav
    Mladenka, Ales
    Dvorackova, Jana
    Bajsova, Sylva
    Simetka, Ondrej
    ANTICANCER RESEARCH, 2019, 39 (01) : 421 - 424
  • [44] Conditional deletion of L1CAM in human neurons impairs both axonal and dendritic arborization and action potential generation
    Patzke, Christopher
    Acuna, Claudio
    Giam, Louise R.
    Wernig, Marius
    Suedhof, Thomas C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 213 (04) : 499 - 515
  • [45] L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary
    Doberstein, Kai
    Spivak, Rebecca
    Reavis, Hunter D.
    Hooda, Jagmohan
    Feng, Yi
    Kroeger, Paul T.
    Stuckelberger, Sarah
    Mills, Gordon B.
    Devins, Kyle M.
    Schwartz, Lauren E.
    Iwanicki, Marcin P.
    Fogel, Mina
    Altevogt, Peter
    Drapkin, Ronny
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [46] Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma
    Schaefer, Heiner
    Dieckmann, Chantal
    Korniienko, Olena
    Moldenhauer, Gerhard
    Kiefel, Helena
    Salnikov, Alexey
    Krueger, Achim
    Altevogt, Peter
    Sebens, Susanne
    CANCER LETTERS, 2012, 319 (01) : 66 - 82
  • [47] Mutations in MAGEL2 and L1CAM Are Associated With Congenital Hypopituitarism and Arthrogryposis
    Gregory, Louise C.
    Shah, Pratik
    Sanner, Juliane R. F.
    Arancibia, Monica
    Hurst, Jane
    Jones, Wendy D.
    Spoudeas, Helen
    Stabej, Polona Le Quesne
    Williams, Hywel J.
    Ocaka, Louise A.
    Loureiro, Carolina
    Martinez-Aguayo, Alejandro
    Dattani, Mehul T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (12) : 5737 - 5750
  • [48] Prenatal Identification of a Novel R937P L1CAM Missense Mutation
    Wilson, Patrick L.
    Kattman, Brandi Blaisdell
    Mulvihill, John J.
    Li, Shibo
    Wilkins, Jesse
    Wagner, Andrew F.
    Goodman, Jean R.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2009, 13 (04) : 515 - 519
  • [49] Myofibroblast-induced tumorigenicity of pancreatic ductal epithelial cells is L1CAM dependent
    Schaefer, Heiner
    Geismann, Claudia
    Heneweer, Carola
    Egberts, Jan-Hendrik
    Korniienko, Olena
    Kiefel, Helena
    Moldenhauer, Gerhard
    Bachem, Max G.
    Kalthoff, Holger
    Altevogt, Peter
    Sebens, Susanne
    CARCINOGENESIS, 2012, 33 (01) : 84 - 93
  • [50] L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma
    Soovares, Piret
    Pasanen, Annukka
    Butzow, Ralf
    Lassus, Heini
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 615 - 622